-
Something wrong with this record ?
High prevalence of the IVS 1 + 1 G to A/GJB2 mutation among Czech hearing impaired patients with monoallelic mutation in the coding region of GJB2
Seeman P, Sakmaryová I.
Language English Country Denmark
Grant support
NM7417
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
NLK
Wiley Online Library (archiv)
from 1997-01-01 to 2012-12-31
- MeSH
- Alleles MeSH
- Financing, Organized MeSH
- Genetic Testing MeSH
- Cohort Studies MeSH
- Connexins genetics MeSH
- Humans MeSH
- RNA Splice Sites genetics MeSH
- Mutation MeSH
- DNA Mutational Analysis MeSH
- Hearing Loss, Bilateral diagnosis epidemiology genetics MeSH
- Restriction Mapping MeSH
- Check Tag
- Humans MeSH
- Geographicals
- Czech Republic MeSH
Biallelic pathogenic GJB2 gene mutations cause pre-lingual genetic hearing loss in up to 50% of individuals with bilateral sensorineural hearing loss worldwide. Sequencing of the entire GJB2 gene-coding region in Czech patients with pre-lingual bilateral hearing loss revealed that 10.3% of Czech patients carry only one monoallelic pathogenic mutation in the coding region of the GJB2 gene, which is significantly more than the population frequency of 3.4%. The 309-kb GJB6 deletion, frequent in Spain and France, is very rare in the Czech population. In order to evaluate the impact of the IVS1 + 1 G to A splice site mutation in the non-coding part of the GJB2 gene among Czech patients, we tested all available patients with pre-lingual hearing loss with only one monoallelic mutation in the coding part of GJB2. By sequencing of the exon 1 region of the GJB2 gene and HphI restriction analysis in 20 Czech patients we identified nine patients carrying IVS1 + 1 G to A. Testing for this mutation explained deafness in 45% of Czech GJB2 monoallelic patients. This mutation represents now 4% of GJB2 pathogenic mutations in Czech patients and is the third most common GJB2 mutation found in our cohort of 242 unrelated Czech patients with prelingual hearing loss. A similar frequency may also be expected in other Central European or Slavic populations.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07522073
- 003
- CZ-PrNML
- 005
- 20130514143252.0
- 008
- 090426s2006 dk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Seeman, Pavel, $d 1966- $7 xx0037870
- 245 10
- $a High prevalence of the IVS 1 + 1 G to A/GJB2 mutation among Czech hearing impaired patients with monoallelic mutation in the coding region of GJB2 / $c Seeman P, Sakmaryová I.
- 314 __
- $a Department of Child Neurology, DNA Laboratory, Charles University Prague, 2nd School of Medicine, Prague, Czech Republic. pseeman@yahoo.com
- 520 9_
- $a Biallelic pathogenic GJB2 gene mutations cause pre-lingual genetic hearing loss in up to 50% of individuals with bilateral sensorineural hearing loss worldwide. Sequencing of the entire GJB2 gene-coding region in Czech patients with pre-lingual bilateral hearing loss revealed that 10.3% of Czech patients carry only one monoallelic pathogenic mutation in the coding region of the GJB2 gene, which is significantly more than the population frequency of 3.4%. The 309-kb GJB6 deletion, frequent in Spain and France, is very rare in the Czech population. In order to evaluate the impact of the IVS1 + 1 G to A splice site mutation in the non-coding part of the GJB2 gene among Czech patients, we tested all available patients with pre-lingual hearing loss with only one monoallelic mutation in the coding part of GJB2. By sequencing of the exon 1 region of the GJB2 gene and HphI restriction analysis in 20 Czech patients we identified nine patients carrying IVS1 + 1 G to A. Testing for this mutation explained deafness in 45% of Czech GJB2 monoallelic patients. This mutation represents now 4% of GJB2 pathogenic mutations in Czech patients and is the third most common GJB2 mutation found in our cohort of 242 unrelated Czech patients with prelingual hearing loss. A similar frequency may also be expected in other Central European or Slavic populations.
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a konexiny $x genetika $7 D017630
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a genetické testování $7 D005820
- 650 _2
- $a oboustranná nedoslýchavost $x diagnóza $x epidemiologie $x genetika $7 D006312
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a místa sestřihu RNA $x genetika $7 D022821
- 650 _2
- $a restrikční mapování $7 D015183
- 650 _2
- $a financování organizované $7 D005381
- 651 _2
- $a Česká republika $7 D018153
- 700 1_
- $a Dolinová, Iva $7 xx0070781
- 773 0_
- $w MED00001127 $t Clinical genetics $g Roč. 69, č. 5 (2006), s. 410-413 $x 0009-9163
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090312170439 $b ABA008
- 991 __
- $a 20130514143604 $b ABA008
- 999 __
- $a ok $b bmc $g 645162 $s 498078
- BAS __
- $a 3
- BMC __
- $a 2006 $b 69 $c 5 $d 410-413 $i 0009-9163 $m Clinical genetics $x MED00001127
- GRA __
- $a NM7417 $p MZ0
- LZP __
- $a 2009-B1/vtme